Search Results 571-580 of 18319 for Hepatitis b

  1. Publications - Fiona E. Craig, M.D. - Mayo Clinic

    Primary cutaneous epidermotropic marginal zone B-cell lymphoma treated with total skin electron beam therapy. ... Epidemiology of acute non-A, non-B hepatitis in ...

  2. Immune thrombocytopenia (ITP) - Symptoms and causes - Mayo Clinic

    Here they appear on a leg (A) and on a belly (B). ... In adults, an infection with HIV , hepatitis or the bacteria that causes stomach ulcers, known as H.

  3. Primary Care in Arizona - Doctors - Mayo Clinic

    Horsley, M.D.. Internist. Phoenix, AZ. Areas of focus: LGBT health care, Erectile dysfunction, Sexual dysfunction, Hepatitis C, Hepatitis B, Sexually ...

  4. MASTER EDUCATION AFFILIATION AGREEMENT between MAYO CLINIC and ST. CLOUD STATE UNIVERSITY This Master Education Affiliation Agre

    (iv) Proof of Hepatitis B immunization or completion of a certificate of ... C. b. Rochester, MN, clinical locations: Students completing rotations in ...

  5. Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068) - Mayo Clinic

    Co-infected with hepatitis B virus; Has had previous direct-acting antiviral treatment; History of malignancy ≤5 years prior except for adequately treated ...

  6. Bacitracin and polymyxin b (topical application route) - Mayo Clinic

    Bacitracin and polymyxin B belong to the class of medicines known as antibiotics. They work by killing the bacteria or preventing their growth. This medicine is ...

  7. Study shows a new scoring system can help clinicians predict 30-day mortality risk for patients with alcohol-associated hepatitis - Mayo Clinic News Network

    The new scoring system, called the Mortality Index for Alcohol-Associated Hepatitis (MIAAH), is at least as accurate as existing models in identifying patients ...

  8. Science Saturday: COVID-19 "Live" Virus Research In a Specialized Lab - Mayo Clinic News Network

    ... hepatitis B and anti-HIV drugs. "These challenges are what we are witnessing during the current COVID-19 pandemic," says Dr. Ebihara. "We are unique and the ...

  9. Publications - Thomas J. Byrne, M.D. - Mayo Clinic

    Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient. Mayo Clin Proc. 2015 Sep; 90: (9)1294-7. View ...

  10. A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    ... B-cell type) subtype will be allocated to Arm B. ... Seropositive or active viral infection with hepatitis B virus, human immunodeficiency virus or hepatitis C ...